The FDA and safety—beyond the heparin crisis
- 1 June 2008
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 26 (6), 621-623
- https://doi.org/10.1038/nbt0608-621
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact SystemNew England Journal of Medicine, 2008
- Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsNature Biotechnology, 2008